The idea of 3D printing a patient’s stem cells to develop and test personalized treatments is one step closer to becoming a reality. In her pioneering study, Vancouver Coastal Health Research Institute researcher Stephanie Willerth lays the groundwork for a personalized medicine approach that could be applied to finding treatments for neurological diseases such as Alzheimer’s and Parkinson’s.
“This may well be the first study to combine cellular reprogramming with 3D bioprinting,” says Willerth, whose lab focuses on studying neural tissues. “I am excited to see how this research may evolve.”
